Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Radziuk 2015.

Methods Open‐label, non‐controlled trial
Participants 30 children and adolescents with epilepsy and comorbid ADHD
Interventions Methylphenidate, type not stated
Outcomes Tolerability to methylphenidate, quality of life, seizure frequency
Notes